Provention bio announces the grant of inducement awards

Red bank, n.j. , dec. 2, 2022 /prnewswire/ -- provention bio, inc. (nasdaq: prvb) (the "company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the company granted stock options to three non-executive employees to purchase an aggregate of 84,000 shares of common stock.
PRVB Ratings Summary
PRVB Quant Ranking